Published in Medical Letter on the CDC and FDA, December 29th, 2002
Metabolife International already had turned over 14,700 customer health complaints as the Justice Department began a criminal investigation into whether the company had lied about ephedra's safety.
Ephedra is a popular herb commonly used for weight loss and body building, but it also has been linked to heart attacks, strokes and other serious side effects. Critics have called on the Food and Drug Administration to ban sales, and the agency has long sought manufacturers' records of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.